about
MutS homologue hMSH5: role in cisplatin-induced DNA damage responseSeparation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutantABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell linesMutS inhibits RecA-mediated strand transfer with methylated DNA substrates.Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerAdvances in diagnosis and treatment of metastatic cervical cancerHistone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancerPharmacogenomics of cisplatin sensitivity in non-small cell lung cancercis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsConsequences of Cisplatin Binding on Nucleosome Structure and DynamicsStructural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyRole of Akt signaling in resistance to DNA-targeted therapyMicroarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinomaATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cellsCompensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signalingComparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agentsInhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoidsConsensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cellsQuantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cellsAberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancerMutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.A modular framework for gene set analysis integrating multilevel omics data.Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines.Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest.A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptorp21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell.Protective effect of Glycine max and Chrysanthemum indicum extracts against cisplatin-induced renal epithelial cell death.Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistanceROR1 expression correlated with poor clinical outcome in human ovarian cancerEnhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine.Cellular responses to Cisplatin-induced DNA damage.
P2860
Q24306821-07F20B87-ABE2-4BB5-A6C4-341F0384B896Q24793829-C8BDE180-A2DC-409F-BDC8-91A6511731EFQ24811443-94C30B09-7532-4469-9811-E8B1533EBB9BQ24811781-59276807-70BC-4F54-801A-7776155F1633Q26741846-8761C5C8-8711-49C3-A19E-C3EC20108C6BQ26750408-4D29841B-8403-4A63-8F92-5A3152019581Q26777453-B2C605D8-1391-4F79-9597-071BDB04CF70Q26863490-BFF7215A-4D43-4D22-8EEA-90C21F042245Q27650949-EF70AA4B-CFD9-481A-B9C4-E4711232AB3BQ27666340-3AE2F677-AA00-465A-AD3F-4EA2A0EDBCE2Q27678933-319BE7D1-AE93-473F-99AF-1E63BBDD1CBEQ28066950-AB5B9D7B-66AE-4CA4-9647-95471403F5AEQ28116304-7A0A2B2A-7B09-438C-8E50-36B9787840E8Q28190506-C6979827-644A-4FE9-AD00-87D60593DF41Q28207249-4320F4D3-0AB9-412D-B332-816347516F97Q28273778-8B960585-BF32-422E-AD14-3C0F1B4A1FECQ28300710-E62B819B-F4FC-403A-ADD3-3A816B0E8542Q28477581-ED1B7A85-3E01-416A-A06E-5521C7FFB2B1Q28478299-BCA9B765-38BF-4A76-800D-5B3DE5DE9480Q28543351-2C766742-93F7-485F-9BAE-05DDB6944452Q30371605-FDDEBC95-7F43-4175-82EC-606A27E4AF8BQ30663351-E76C157A-227D-4473-849F-FE963D20849AQ31034514-B79657C6-90B2-4136-8CDC-67AAECC7CD3BQ33194000-5AF47639-DCE5-44E8-BB93-A00C56FCC261Q33217218-7B4710A1-120C-4F20-8D90-20F06B51CB09Q33317781-A42A7746-72CD-4AD9-B3A1-625D1BBC9003Q33578400-ACEBDCA5-5945-4C10-904A-E67ABC2235D5Q33615259-D42ABCB7-815E-4465-AA8A-F43F343A725BQ33642960-5A2AD2E6-148E-4149-9BBA-B2859CC3805FQ33750796-DF5E5040-8995-47C6-A8A6-6C9D636796C0Q33846828-5A9FF9B0-83A4-43FB-A76B-3A2A9DA5C173Q33868777-E40CD401-EA70-4129-BA03-2F1048E2D3CBQ33925154-31DBB340-95FB-43DF-A7AF-68C7BD7D1CA1Q33941309-C6DB71E4-7070-4344-99E7-F28C6B2FD8CFQ33942010-D68E0E1E-5FE0-4A1D-9AE6-272B24B8BFC5Q33965570-B9151CCE-F759-433B-A44F-4CC9068AC9F9Q34060461-46B77F4B-ED20-41A5-A281-5B22AA61A020Q34072810-E603E84F-3403-457C-A05D-0AFD87E7E545Q34076504-96A7083E-DE97-42B0-A888-5FDFCC660096Q34089685-84C7907E-65F1-48A0-B2C1-FFDC443F6EEF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mechanisms of resistance to cisplatin.
@ast
Mechanisms of resistance to cisplatin.
@en
Mechanisms of resistance to cisplatin.
@nl
type
label
Mechanisms of resistance to cisplatin.
@ast
Mechanisms of resistance to cisplatin.
@en
Mechanisms of resistance to cisplatin.
@nl
prefLabel
Mechanisms of resistance to cisplatin.
@ast
Mechanisms of resistance to cisplatin.
@en
Mechanisms of resistance to cisplatin.
@nl
P1433
P1476
Mechanisms of resistance to cisplatin.
@en
P2093
J M Essigmann
M Kartalou
P356
10.1016/S0027-5107(01)00141-5
P407
P577
2001-07-01T00:00:00Z